Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
American Heart Journal|June 7, 2011
Depressive symptoms and inflammation in patients hospitalized for heart failurePeter Johansson, Ivonne Lesman-Leegte, Erland Svensson, et al.
European Heart Journal|April 23, 2009
Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trialStefan D Anker, Adriaan Voors, Darlington Okonko, et al.
Journal of Cardiac Failure|November 14, 2020
Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI TrialSteven R Goldsmith, Daniel Burkhoff, Finn Gustafsson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 8, 2026
Vessel-specific angiography-derived index of microcirculatory resistance in an all-comer population undergoing percutaneous coronary intervention, a PIONEER IV trial substudyChris Lenselink, Kim Ricken, Tsung-Ying Tsai, et al.
Journal of Cardiac Failure|September 18, 2016
Progression of Renal Impairment and Chronic Kidney Disease in Chronic Heart Failure: An Analysis From GISSI-HFKevin Damman, Serge Masson, Donata Lucci, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 11, 2025
Long-term age-stratified outcomes after surgical and transcatheter aortic valve replacement: a Dutch cohort studyKees van Bergeijk, Stijn Venema, Ad van den Heuvel, et al.
Hypertension (Dallas, Tex. : 1979)|February 17, 2026
Neutrophil Gelatinase-Associated Lipocalin Drives Cardiac Remodeling in Rats With Chronic Kidney DiseaseMatthieu Soulié, Tania Sánchez-Bayuela, Ixchel Lima-Posada, et al.
ESC Heart Failure|July 10, 2024
Eligibility of Asian and European registry patients for phase III trials in heart failure with reduced ejection fractionYvonne Mei Fong Lim, Folkert W Asselbergs, Ayoub Bagheri, et al.
Clinical Cardiology|May 22, 2018
Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HFAmanda K Verma, Jie-Lena Sun, Adrian Hernandez, et al.
Lancet (London, England)|August 31, 2012
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trialScott D Solomon, Michael Zile, Burkert Pieske, et al.
Pageof 4